FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis
U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (cardiomyopathy) caused... Read More
Top 10 Generic Company Globally in 2018 (by revenue)
Here you can preview top 10 global generic companies by revenue. Data is presented in USD million. KPE – C- 024 KPE’s... Read More